Joseph W. LaPlume, EVP, Corporate Strategy & Develop at CHARLES RIVER LABORATORIES INTERNATIONAL INC (CRL), sold 6,135 shares at $137.84 ($847K) on 2019-03-08, disclosed to the SEC on 2019-03-12.
Open-market sale of $847k CRL by EVP, Corporate Strategy & Develop. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $137.84 | 200 | $28K | 3.3% |
| 2 | $137.84 | 200 | $28K | 3.3% |
| 3 | $137.85 | 200 | $28K | 3.3% |
| 4 | $137.86 | 99 | $14K | 1.6% |
| 5 | $137.87 | 300 | $41K | 4.9% |
| 6 | $137.88 | 100 |
| $14K |
| 1.6% |
| 7 | $137.89 | 100 | $14K | 1.6% |
| 8 | $137.90 | 300 | $41K | 4.9% |
| 9 | $137.91 | 299 | $41K | 4.9% |
| 10 | $137.92 | 200 | $28K | 3.3% |
| 11 | $137.97 | 195 | $27K | 3.2% |
| 12 | $137.98 | 100 | $14K | 1.6% |
| 13 | $137.99 | 230 | $32K | 3.7% |
| 14 | $138.00 | 100 | $14K | 1.6% |
| 15 | $138.01 | 11 | $2K | 0.2% |
| 16 | $138.01 | 5 | $690 | 0.1% |
| 17 | $138.02 | 5 | $690 | 0.1% |
| 18 | $138.02 | 300 | $41K | 4.9% |
| 19 | $138.03 | 30 | $4K | 0.5% |
| 20 | $138.03 | 300 | $41K | 4.9% |
| 21 | $138.03 | 30 | $4K | 0.5% |
| 22 | $138.04 | 100 | $14K | 1.6% |
| 23 | $138.05 | 108 | $15K | 1.8% |
| 24 | $138.06 | 60 | $8K | 1.0% |
| 25 | $138.06 | 240 | $33K | 3.9% |
| 26 | $138.06 | 60 | $8K | 1.0% |
| 27 | $138.07 | 300 | $41K | 4.9% |
| 28 | $138.08 | 600 | $83K | 9.8% |
| 29 | $138.09 | 70 | $10K | 1.1% |
| 30 | $138.10 | 137 | $19K | 2.2% |
| 31 | $138.10 | 70 | $10K | 1.1% |
| 32 | $138.14 | 200 | $28K | 3.3% |
| 33 | $138.15 | 507 | $70K | 8.3% |
| 34 | $138.16 | 179 | $25K | 2.9% |
| 35 | $138.17 | 200 | $28K | 3.3% |
| Total | $138.01 avg | 6,135 | $847K | 100% |
| Filing → |
| CRL | SELL | 2025-08-20 | $126K | — | Filing → |
| CRL | SELL | 2025-08-08 | $60K | — | Filing → |
| CRL | SELL | 2025-05-15 | $73K | — | Filing → |